NCT05557916

Brief Summary

RCT to determine if a less restrictive postoperative rehabilitation protocol following meniscal repair results in a faster return to normal knee function without compromising rates of healing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 28, 2022

Status Verified

September 1, 2022

Enrollment Period

2.9 years

First QC Date

February 20, 2022

Last Update Submit

September 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Biodex isokinetic quadriceps strength at 6 months

    Patients will undergo Biodex Isokinetic measurement at 6 months

    six months

Secondary Outcomes (9)

  • Rates of failure

    two years

  • Knee injury and Osteoarthritis Outcome Score (KOOS)

    preoperative, six months, two years

  • Change from baseline Biodex isokinetic quadriceps strength at 24 months

    2 years

  • Goniometric measurement: Knee flexion and extension

    2 weeks, 6 weeks, 6 months, 2 years

  • IKDC

    Pre-operative, 6 months, 2 years

  • +4 more secondary outcomes

Study Arms (2)

Standard rehab group

ACTIVE COMPARATOR

This group will follow the clinics standard rehab protocol, wherein they have a knee orthosis for six weeks, with flexion limited to 0-30 degress week 0-2, 0-60 degrees week 2-4 and 0-90 degrees week 4-6. Crouching is not permitted week 6-12.

Other: Standard rehab

Accelerated rehab group

ACTIVE COMPARATOR

accelerated rehab group, wherein they are permitted to perform range of motion training within their comfort zone. Running is permitted after 8 weeks, contact sports 4 months postoperatively

Other: accelerated rehab group

Interventions

Standard rehab protocol including knee orthosis following meniscal repair

Standard rehab group

accelerated rehab group, no orthosis

Accelerated rehab group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Meniscal tear in the peripheral zone of the meniscus, repaired using at least two sutures.

You may not qualify if:

  • Associated injury of the knee requiring surgical or non-surgical intervention that precludes the patient from completing accelerated rehabilitation- fracture, concomitant ligament or cartilage injury.
  • Previous meniscal repair in the affected meniscus
  • BMI over 30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centrum för idrottsforskning och utbildning (CIFU)

Stockholm, 11427, Sweden

RECRUITING

Karolinska University Hospital

Stockholm, 141 86, Sweden

RECRUITING

Study Officials

  • Erik Rönnblad

    Centrum för idrottsforskning och utbildning (CIFU) Adress: Valhallavägen 91, 11427 Stockholm

    STUDY DIRECTOR

Central Study Contacts

Sebastian D McCallum, MBBS

CONTACT

Christoffer Von Essen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

February 20, 2022

First Posted

September 28, 2022

Study Start

January 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 28, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations